|
|
||||||||
1Departments of Medicine and Physiology, Cardiovascular Research Institute, and Departments of 2Pediatrics and 3Pathology, University of California, San Francisco, California 94143
Submitted 6 October 2003 ; accepted in final form 26 June 2004
Nasal potential difference (PD) measurements have been used to demonstrate defective CFTR function in cystic fibrosis (CF) and to evaluate potential CF therapies. We used the selective thiazolidinone CFTR inhibitor CFTRinh-172 to define the involvement of CFTR in nasal PD changes in mice and pigs. In normal mice infused intranasally with a physiological saline solution containing amiloride, nasal PD was 4.7 ± 0.7 mV, hyperpolarizing by 15 ± 1 mV after a low-Cl solution, and a further 3.9 ± 0.5 mV after forskolin. CFTRinh-172 produced 1.1 ± 0.9- and 4.3 ± 0.7-mV depolarizations when added after low Cl and forskolin, respectively. Systemically administered CFTRinh-172 reduced the forskolin-induced hyperpolarization from 4.7 ± 0.4 to 0.9 ± 0.1 mV but did not reduce the low Cl-induced hyperpolarization. Nasal PD was 12 ± 1 mV in CF mice after amiloride, changing by <0.5 mV after low Cl or forskolin. In pigs, nasal PD was 14 ± 3 mV after amiloride, hyperpolarizing by 13 ± 2 mV after low Cl and a further 9 ± 1 mV after forskolin. CFTRinh-172 and glibenclamide did not affect nasal PD in pigs. Our results suggest that cAMP-dependent nasal PDs in mice primarily involve CFTR-mediated Cl conductance, whereas cAMP-independent PDs are produced by a different, but CFTR-dependent, Cl channel. In pigs, CFTR may not be responsible for Cl channel-dependent nasal PDs. These results have important implications for interpreting nasal PDs in terms of CFTR function in animal models of CFTR activation and inhibition.
cystic fibrosis; cystic fibrosis transmembrane conductance regulator; nasal potential difference; chloride channels
This article has been cited by other articles:
![]() |
C. Routaboul, C. Norez, P. Melin, M.-C. Molina, B. Boucherle, F. Bossard, S. Noel, R. Robert, C. Gauthier, F. Becq, et al. Discovery of {alpha}-Aminoazaheterocycle-Methylglyoxal Adducts as a New Class of High-Affinity Inhibitors of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1023 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, M. Luo, L. Zhang, W. Ding, Z. Yan, and J. F. Engelhardt Bioelectric Properties of Chloride Channels in Human, Pig, Ferret, and Mouse Airway Epithelia Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 313 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Akiba, M. Jung, S. Ouk, and J. D. Kaunitz A novel small molecule CFTR inhibitor attenuates HCO3- secretion and duodenal ulcer formation in rats Am J Physiol Gastrointest Liver Physiol, October 1, 2005; 289(4): G753 - G759. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |